aEgIS Biologics
Latest round
- Series A
Last raised
- Feb 2020
Total raised
- $3.4M
Investors
- 1
About aEgIS Biologics
Based in Suwon, South Korea, and founded in 2018, aEgIS Biologics formerly known as Kynogen specializes in the research and development of pharmaceutical treatments and platforms for cancer. The company’s core product, KG-IM-001, is designed to overcome resistance and improve efficacy in treating severe immune disorders. This biologic candidate targets key pathways involved in immune regulation, aiming to provide safer and more effective alternatives to conventional treatments. aEgIS Biologics also engages in R&D for additional therapeutic platforms addressing unmet needs in immunology.
Who invested in aEgIS Biologics
1 investor across 1 round
See all investors in aEgIS Biologics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 1, 2020
Amount
$3.4M
Investors
Questions about aEgIS Biologics
Who invested in aEgIS Biologics?
aEgIS Biologics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has aEgIS Biologics raised?
aEgIS Biologics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did aEgIS Biologics last raise money?
aEgIS Biologics's most recent round on record is a Series A, in Feb 2020.
What does aEgIS Biologics do?
Based in Suwon, South Korea, and founded in 2018, aEgIS Biologics formerly known as Kynogen specializes in the research and development of pharmaceutical treatments and platforms for cancer.
Where is aEgIS Biologics headquartered?
aEgIS Biologics is headquartered in Suwon-si, South Korea.
Which VCs invest in companies like aEgIS Biologics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at aEgIS Biologics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like aEgIS Biologics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.